Form4insider filings, from the source

SEC Form 4 · accession 0000904454-15-000217

Esperion Therapeutics, Inc. · ESPR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jesse I Treu
10% Owner
James C Blair
10% Owner
Nicole Vitullo
Director · 10% Owner
Brian H Dovey
10% Owner
Brian K Halak
10% Owner
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5,F6Mar 20, 2015J350,000—D2,216,935D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses